Benzene polyphosphates as tools for cell signalling: inhibition of inositol 1,4,5‐trisphosphate 5‐phosphatase and interaction with the PH domain of protein kinase Bα
Mills, S. J., Vandeput, F., Trusselle, M. N., Safrany, S. T., Erneux, C. and Potter, B. V. L., 2008. Benzene polyphosphates as tools for cell signalling: inhibition of inositol 1,4,5‐trisphosphate 5‐phosphatase and interaction with the PH domain of protein kinase Bα. ChemBiochem, 9 (11), pp. 1757-1766.
Related documents:This repository does not currently have the full-text of this item.
You may be able to access a copy if URLs are provided below. (Contact Author)
Novel benzene polyphosphates were synthesised as inositol polyphosphate mimics and evaluated against type-1 inositol 1,4,5-trisphosphate 5-phosphatase, which only binds soluble inositol polyphosphates, and against the PH domain of protein kinase B alpha (PKB alpha), which can bind both soluble inositol polyphosphates and inositol phospholipids. The most potent trisphosphate 5-phosphotase inhibitor is benzene 1,2,4-trisphosphote (2, IC50 of 14 mu m), a potential mimic of D-myo-inositol 1,4,5-trisphosphate, whereas the most potent tetrakisphosphote Ins(1,4,5)P, 5-phosphotase inhibitor is benzene 1,2,4,5-tetrakisphosphate, with an IC50 of 4 mu M. Biphenyl 2,3',4,5',6-pentakisphosphate (4) was the most potent inhibitor evaluated against type 1 Ins(1,4,5)P-3 5-phosphatase (IC50 of 1 mu M). All new benzene polyphosphates are resistant to dephosphorylation by type 1 Ins(1,4,5)P-3 5-phosphatose. Unexpectedly, all benzene polyphosphates studied bind to the PH domain of PKBa with apparent higher affinity than to type I Ins(1,4,5)P3 5-phosphatase. The most potent ligand for the PKBa PH domain, measured by inhibition of biotinylated diC(8)-PtdIns(3,4)P-2 binding, is biphenyl 2,3',4,5',6-pentakisphosphate (4, K-i = 27 nM). The approximately 80-fold enhancement of binding relative to parent benzene trisphosphate is explained by the involvement of a cation-pi interaction. These new molecular tools will be of potential use in structural and cell signalling studies.
|Creators||Mills, S. J., Vandeput, F., Trusselle, M. N., Safrany, S. T., Erneux, C. and Potter, B. V. L.|
|Departments||Faculty of Science > Pharmacy & Pharmacology|
Actions (login required)